SCHEMBL14735229

SCHEMBL14735229

CC(CC(N)=O)c1ccc(C(=O)O)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
ACE2 Q9BYF1 4/20 0.43
GRM1 Q13255 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA7 P43166 1/20 0.37
TPMT P51580 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14735298 0.83 TDP1 (0.46) HTTRAB9AACE2GRM1MEN1
SCHEMBL12491998 0.83 ACE2 (0.60) LMNAMAPK1HTTRAB9AACE2
SCHEMBL9160661 0.83 CES2 (0.45)
SCHEMBL14735528 0.82 TSHR (0.47) ACE2GRM1MEN1CYP1A2KMT2A
SCHEMBL3649293 0.79 GRM1 (0.51) LMNAMAPK1HTTRAB9AACE2
SCHEMBL12584011 0.79 GRM1 (0.51) LMNAMAPK1HTTRAB9AACE2
SCHEMBL2627846 0.79 ACE2 (0.56) LMNAMAPK1HTTRAB9AACE2
Hydrochloric Acid SCHEMBL3654866 0.78 GRM1 (0.50) LMNAMAPK1HTTRAB9AACE2
Hydrochloric Acid SCHEMBL20539066 0.78 GRM1 (0.50) LMNAMAPK1HTTRAB9AACE2
Hydrochloric Acid SCHEMBL6559020 0.78 GRM1 (0.50) LMNAMAPK1HTTRAB9AACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8598355-B2 Amide compound ASTELLAS PHARMA INC. (JP) 2013-12-03 US disclosed
EP-2565191-A1 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy Astellas Pharma Inc. (JP) 2013-03-06 EP disclosed